WGS INVESTORS: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announced a securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) for allegedly making false statements regarding the Fabric Genomics acquisition. GeneDx revealed significant problems with the acquisition on May 4, 2026, including a drop in adjusted gross margin from 74% to 69%, reduced earnings projections, and a $31.3 million impairment loss, causing the stock to plummet over 49%. Investors with substantial losses can seek appointment as lead plaintiff by August 3, 2026.